ClinSync Clinical Research Pvt Ltd
Hyderabad-based ClinSync Clinical Research is a CRO providing BA/BE studies, Phase II-IV clinical trials, bioanalytical services, and clinical data management to pharmaceutical, biotech, biosimilar, and medical device sponsors. Founded 2011, it operates a 160-bed facility staffed by 130+ professionals.
- Company typePrivate
- Founded2011
- HeadquartersHyderabad (Madeenaguda), India
- Headcount101–250
- GTM typeB2B
- OfferingServices
What ClinSync Clinical Research Pvt Ltd does
ClinSync Clinical Research Pvt. Ltd. is a Hyderabad-based contract research organization (CRO) established in 2011 that delivers end-to-end clinical research services to pharmaceutical, biotech, biosimilar, and medical device sponsors. Its service portfolio spans Bioavailability/Bioequivalence (BA/BE) studies, Phase II-IV clinical trial operations, bioanalytical method development and sample analysis, clinical data management, pharmacokinetics and biostatistics, pharmacovigilance, medical writing, cold-chain sample management, and (since 2022) FMCG/personal healthcare testing. The company reports more than 390 completed BA/BE studies, 14+ clinical trials, and 100+ method validations across its history, with named customers including Hetero, Aurobindo, Sun Pharma, Alembic, MSN Laboratories, Syngene, Mayo Clinic, and OmniActive.
The company's technical platform is anchored by a 160-bed clinical pharmacology unit (with ICU facilities) at Madeenaguda, Hyderabad, and eight LC-MS/MS systems (API 4000 and API 4500) capable of processing over 30,000 samples per month. Bioanalytical work is supported by a method data bank of 100+ validated assays aligned with FDA, EMEA, NPRA, ANVISA, TGA, and DCGI standards, and clinical data management operates across Medidata Rave, Oracle Clinical RDC, Data Labs, and Inform under 21 CFR Part 11 compliant systems. Pharmacokinetic analysis is performed in Phoenix WinNonlin (v8.3) with statistical analysis in SAS (v9.4), supporting parallel, 2-way crossover, 3-way reference replicate, and 4-way full replicate designs. ClinSync has cleared six USFDA inspections, including a 2023 inspection with zero 483 observations, and holds DSIR recognition in addition to CDSCO, GCC, and NPRA accreditations.
ClinSync operates a fee-for-service, project-based B2B model: revenue is generated through customized study contracts, with pricing determined by study type, complexity, therapeutic area, subject count, and regulatory submission target. Go-to-market is direct enterprise sales via a dedicated business development team, supplemented by participation in industry events and inbound inquiries through [email protected]. The company is privately held, founder/management-owned (per available data, with no disclosed institutional backers or funding rounds), employs 130-148 professionals, and is headquartered in Telangana, India, serving clients across South Asia and select global sponsors.
ClinSync Clinical Research Pvt Ltd firmographics
Firmographics- Name
- ClinSync Clinical Research Pvt Ltd
- Legal name
- ClinSync Clinical Research Pvt. Ltd.
- Website
- https://clinsync.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Hyderabad-based ClinSync Clinical Research is a CRO providing BA/BE studies, Phase II-IV clinical trials, bioanalytical services, and clinical data management to pharmaceutical, biotech, biosimilar, and medical device sponsors. Founded 2011, it operates a 160-bed facility staffed by 130+ professionals.
- Ownership category
- akta.pro rank
ClinSync Clinical Research Pvt Ltd industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- DMPK / ADME & Bioanalysis (HLAGAFAC), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where ClinSync Clinical Research Pvt Ltd is headquartered
LocationHeadquarters
- HQ city
- Hyderabad (Madeenaguda)
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
ClinSync Clinical Research Pvt Ltd business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Research Services: Fee-for-service B2B model providing end-to-end clinical research services to pharmaceutical, biotech, biosimilar, and medical device companies. Revenue generated through project-based contracts for BA/BE studies, clinical trials, data management, bioanalytical services, and medical writing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based service pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
ClinSync Clinical Research Pvt Ltd product offering
Product offeringCore offering
ClinSync Clinical Research Pvt Ltd is a Contract Research Organization that delivers outsourced clinical research services to pharmaceutical, biotechnology, biosimilar, and medical device companies. The company conducts Bioavailability/Bioequivalence (BA/BE) studies, Phase II-IV clinical trials, clinical data management, and bioanalytical laboratory analyses on a fee-for-service basis.
Product overview
ClinSync Clinical Research Pvt Ltd is a Contract Research Organization (CRO) established in 2011 in India, providing comprehensive end-to-end services to pharmaceutical, biotech, biosimilar, and medical device industries. The company operates as a unified platform offering BA/BE Studies (390+ completed), Clinical Trial Operations (Phase II-IV), Clinical Data Management, Bioanalytical Services, Clinical Pharmacology, Pharmacokinetics/Biostatistics, Medical Writing, Cold Chain Management, and Personal Healthcare (FMCG) testing services. With a 160-bed clinical facility and 130+ professionals, the company integrates these services to support drug development from early-phase bioequivalence studies through late-phase clinical trials and regulatory submissions.
Differentiator
Problem solved
Functional benefit
Products and services
- Bioavailability/Bioequivalence (BA/BE) Studies Conducted for pharmaceutical and biosimilar manufacturers requiring regulatory bioequivalence data for generic drug submissions and comparative pharmacokinetic studies.
- Clinical Trials (Phase II-IV) Phase II through Phase IV clinical trial design, conduct, and monitoring services for pharmaceutical, biotechnology, and medical device sponsors across multiple therapeutic areas.
- Clinical Data Management Clinical trial database design, data entry, validation, discrepancy management, and database lock services for sponsors running clinical studies.
- Bioanalytical Services Laboratory bioanalytical method development, validation, and sample analysis for pharmacokinetic, bioavailability, and bioequivalence studies, supporting both clinical trials and standalone bioanalytical projects.
Quantifiable outcome
- 390+ BA/BE studies completed
- +6 more outcomes
Companies that use ClinSync Clinical Research Pvt Ltd
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles2 records
ClinSync Clinical Research Pvt Ltd technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ClinSync Clinical Research Pvt Ltd partnerships and signals
Strategic signalScale indicators11 records
Recent moves9 records
Expansion highlights5 records
ClinSync Clinical Research Pvt Ltd competitors and assessment
Company assessmentDirect peers
- Syngene International: India-based integrated CRO/CDMO serving global pharma and biotech with clinical development, bioanalytical, and data management services. Syngene is a direct peer — also a listed ClinSync customer and competitor for outsourced clinical and bioanalytical work out of India.
- Lambda Therapeutic Research: Indian CRO providing BA/BE, Phase I-IV clinical trials, bioanalytical, and clinical data management services. Lambda is a direct competitor targeting the same generic and biosimilar sponsor base with similar service breadth.
- Cliantha Research: Indian CRO with multi-therapeutic clinical research, bioanalytical, and dermatology/cosmetics testing capabilities. Cliantha competes with ClinSync in both pharma BA/BE and the Personal Healthcare/FMCG testing vertical ClinSync launched in 2022.
- Veeda Clinical Research: Indian CRO headquartered in Ahmedabad offering BA/BE studies, bioanalytical services, and clinical research across therapeutic areas. Veeda is one of ClinSync's closest head-to-head competitors for Indian generic sponsor BA/BE and Phase II-IV outsourcing.
- GVK BIO (Aragen): Hyderabad-headquartered CRO/CDMO offering clinical research, bioanalytical, and discovery services to global pharma. GVK BIO is a directly comparable Indian CRO competing for the same Hyderabad-based sponsor relationships and talent pool.
Broad incumbents
- Parexel International: Global CRO offering Phase I-IV clinical operations, bioanalytical, regulatory, and post-approval services. Parexel is a broad incumbent competitor for multi-country Phase II-IV and bioequivalence work that large pharma sponsors might award instead of a mid-sized Indian CRO.
- IQVIA: Global full-service CRO and clinical technology provider. IQVIA is a broad incumbent that competes for the same Phase II-IV clinical trial and bioanalytical work as ClinSync, with substantially larger global footprint, therapeutic breadth, and scale.
- Labcorp Drug Development (formerly Covance): Global CRO with extensive bioanalytical, central lab, and early-stage clinical capabilities. Labcorp is a broad incumbent that competes for global pharma BA/BE and Phase II-IV work, including USFDA-submission programs that Indian CROs target.
- Charles River Laboratories: Global CRO providing bioanalytical, safety, and clinical research services. Charles River is a broad incumbent competing for the same regulated bioanalytical and Phase II-IV work, particularly for large pharma and biotech sponsors.
Regional players
- Pharmaron: China-headquartered CRO/CDMO offering laboratory, bioanalytical, and clinical research services across geographies. Pharmaron is a regional peer — operates in the same Asia-based outsourcing value proposition that Indian CROs like ClinSync compete within for global sponsor BA/BE and clinical work.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
ClinSync Clinical Research Pvt Ltd social profiles
Digital presenceClinSync Clinical Research Pvt Ltd financial estimates
Financial estimateRevenue estimate
Valuation estimate
ClinSync Clinical Research Pvt Ltd leadership team
Management profileNumber of profiles
ClinSync Clinical Research Pvt Ltd funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ClinSync Clinical Research Pvt Ltd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ClinSync Clinical Research Pvt Ltd
What does ClinSync Clinical Research Pvt Ltd do?
ClinSync Clinical Research Pvt Ltd is a Contract Research Organization that delivers outsourced clinical research services to pharmaceutical, biotechnology, biosimilar, and medical device companies. The company conducts Bioavailability/Bioequivalence (BA/BE) studies, Phase II-IV clinical trials, clinical data management, and bioanalytical laboratory analyses on a fee-for-service basis.
Is ClinSync Clinical Research Pvt Ltd a public or private company?
ClinSync Clinical Research Pvt Ltd is a private company. It is classified as unknown and is currently operating.
When was ClinSync Clinical Research Pvt Ltd founded?
ClinSync Clinical Research Pvt Ltd was founded in 2011. It employs 101 to 250 people.
Where is ClinSync Clinical Research Pvt Ltd based?
ClinSync Clinical Research Pvt Ltd is headquartered in Hyderabad (Madeenaguda), India, in the Asia region.
How does ClinSync Clinical Research Pvt Ltd make money?
One revenue line is on record: clinical Research Services.
Who are ClinSync Clinical Research Pvt Ltd's main competitors?
Direct peers on record are Syngene International, Lambda Therapeutic Research, Cliantha Research, Veeda Clinical Research and GVK BIO (Aragen). Broad incumbents are Parexel International, IQVIA, Labcorp Drug Development (formerly Covance) and Charles River Laboratories. Pharmaron is listed as a regional player.
Does ClinSync Clinical Research Pvt Ltd have an API?
No public API is recorded for ClinSync Clinical Research Pvt Ltd.
What industry is ClinSync Clinical Research Pvt Ltd in?
ClinSync Clinical Research Pvt Ltd's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAFAC, DMPK / ADME & Bioanalysis. Its NAICS code is 54171 and its SIC code is 8731.